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Abstract.  Recycling of 46,000 Mr mannose 6-phos- 
phate receptor (MPR 46) was investigated by microin- 
jection of Fab fragments against small epitopes within 
the cytoplasmic domain of the receptor.  Fab fragments 
against the peptide 43-47 (Ala-Tyr-Arg-Gly-Val) 
efticiently blocked return of MPR 46 to the TGN. 
Antibody-induced redistribution resulted in accumula- 
tion of MPR 46 within an endosomal compartment, 
from which it recycled to the plasma membrane.  Rab5 
and rab7, markers for early and late endosomes, 
respectively, were not detectable in the compartment 
of redistributed MPR 46,  suggesting that it represents 
a  specialized endosomal subcompartment.  The bulk of 
redistributed MPR 46 did not colocalize with endocy- 
tosed fluid-phase marker,  suggesting that it accumu- 
lates at a  site where MPR 46 has been segregated 
from endocytosed material,  which is destined for 
transport to lysosomes. Peptide 43-47 contains a tyro- 
sine (residue 44) which has been shown earlier to be 
part of an internalization  signal for MPR 46 (Johnson, 
K.  E, W. Chan,  and S. Kornfeld.  1990.  Proc.  Natl. 
Acad.  Sci.  USA.  87:10010-10014).  The role of tyrosine 
residue 44 as part of a putative multifunctional  sorting 
signal is discussed. 
M 
PR 46 (46,000 Mr mannose 6-phosphate  receptor)  ~ 
is one of the two receptors that are involved in sort- 
ing and transport of newly synthesized lysosomal 
enzymes  (for review  see Kornfeld  and  MeUman,  1989). 
46,000 Mr MPR (MPR 46)  is thought  to bind lysosomal 
enzymes in the TGN for segregation  from resident Golgi 
proteins and from proteins of the secretory pathway. After 
transfer  to  the  endosomal  compartment,  receptor-ligand 
complexes dissociate due to the acidic pH. Lysosomal en- 
zymes reach their  final destination  by an unknown  mecha- 
nism,  whereas MPR 46 recycles back to the TGN.  While 
sorting  of newly synthesized  lysosomal enzymes towards 
lysosomes is carried out by both, MPR 46 and the 300,000 
Mr MPR (MPR 300),  only MPR 46 mediates export of a 
portion of the lysosomal enzymes (Chao et al.,  1990).  On 
the other hand, binding of lysosomal enzymes at the cell sur- 
face and receptor-mediated endocytosis is a unique function 
of MPR 300 (Stein et al.,  1987). Nevertheless,  MPR 46 is 
transported to the plasma membrane and recycles between 
plasma membrane and endosomes. 
The functional  diversity of the two MPRs is reflected by 
their overlapping  but not identical  subcellular distribution. 
By immunoelectron microscopy, both receptors were found 
in  the  TGN  and  in  early  as  well  as  late  endosomes 
(Bleekemolen et al., 1988; Matovcik et al., 1990). In the en- 
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dosomal compartment,  however, partial  segregation  of the 
two receptors has been observed (Klumperman et al., 1993). 
MPR 300 was found to be enriched in the large vacuolar part 
of endosomes, when compared with associated tubular ex- 
tensions  and small vesicles surrounding  the endosomes (re- 
ferred to as ATV). The ratio of immunogold-labeled  MPR 
46 over MPR 300 was higher  in ATV than in the vacuolar 
part of the endosomes, suggesting differential sorting of the 
two receptors. 
In most instances,  sorting of receptors is regulated by sig- 
nals in their cytoplasmic domain, which are recognized  by 
cytosolic transport  factors.  Though  recently  it  has  been 
postulated that also the extraceUular or transmembrane do- 
mains play a role for recycling of MPR 300, the signals in- 
volved have not been identified to date (Dintzis and Pfeffer, 
1990).  The sorting of receptors into clathrin-coated  pits of 
the plasma membrane depends on a tyrosine residue,  or an 
aromatic amino acid as part of an internalization  signal in 
their cytoplasmic domain. This signal is recognized by HA-2 
adaptors, the protein complex which induces the assembly 
of the clathrin  coat around receptors at the plasma mem- 
brane  (for review  see Pearse and  Robinson,  1990).  The 
tyrosine-containing  internalization  signal is thought to be ex- 
posed in a B-turn conformation within the cytoplasmic do- 
main as shown for low density lipoprotein  (LDL) receptor, 
transferrin receptor, and lysosomal acid phosphatase (Bansal 
and Gierasch,  1991; Collawn et al.,  1990; Ktistakis  et al., 
1990; Eberle et al.,  1991). For the rapid internalization  of 
MPR 46, a more complex signal has been characterized  by 
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two distinct internalization signals in the cytoplasmic do- 
main of bovine MPR 46,  the first signal including amino 
acids Phe-12 and Phe-17, and the second including Tyr-44. 
For the rapid endocytosis of human MPR 46 the last seven 
amino acids of  the cytoplasmic domain proved to be essential 
(Weber et al., in preparation). 
A second clathrin-dependent pathway is involved in trans- 
port from the TGN to the endosomal compartment. HA1 
adaptors, which are thought to mediate assembly of coated 
vesicles at the TGN, have been shown to bind to an as yet 
unidentified signal in the cytoplasmic domain of MPR 300 
and MPR 46 (Glickman et al., 1989; Sosa et al., 1993). Ad- 
ditional signals that regulate exit from the endosomal com- 
partment and recycling of receptors to the TGN or to the 
plasma membrane, and putative cytosolic proteins involved 
in these sorting steps remain to be characterized. 
We have used peptide-specific antibodies that recognize 
small peptide epitopes within the cytoplasmic domain of hu- 
man MPR 46 to screen for sorting signals involved in its in- 
traceUular transport. In the present study we show that F 
fragments against peptide 38-52 of the cytoplasmic domain 
of MPR 46, when microinjected into human fibroblasts, pre- 
vent recycling of MPR 46 to the TGN, resulting in accumula- 
tion of MPR 46 in a vesicular compartment that is related 
to endosomes. Antibodies against the peptide Ala-Tyr-Arg- 
Gly-Val, which constitutes the central  epitope of peptide 
38-52, were most efficient in causing this redistribution. An- 
tibodies against peptide 7-21 did not alter the distribution of 
MPR 46. 
Materials and Methods 
Cells 
Human llbroblasts were obtained from a skin biopsy for diagnostic purpose 
and cultured as previously described (Sly and Grubb, 1979).  BHK 21 cells 
overexpressing human  MPR 46  were  cultured  as previously described 
(Wendland et al.,  1991). 
Peptide-specific  Antibodies and F. Fragments 
Antisera against synthetic peptides which correspond to amino acids 7-21 
(peptide A) and 38-52 (peptide B) of the cytoplasmic domain of human 
MPR 46 (starting with Arg 212 as amino acid no.  1) have been described 
earlier (Nadimpalli et al.,  1991). 
Affinity purification of antibodies was performed with peptides that had 
been coupled to Affigel 10 (Bio-Rad, Mfinchen, Germany) as described 
(Nadimpalli et al., 1991; Geuze et al., 1984).  To subfractionate antibodies 
against peptide B,  sequential chromatography of the antiserum was per- 
formed on  immobilized decapeptides as  outlined  in  Fig.  1.  For  each 
decapeptide, rechromatugraphy was performed to deplete all antibodies that 
were specific for the immobilized peptide before the antiserum was loaded 
to the subsequent peptide column. 
Fab fragments of affinity-purified antibodies were generated by digestion 
with papain at a ratio of 1 nag papaln per 50 mg of antibody for 30 min at 
370C  as previously described (Hille et al.,  1992). 
Immunoprecipitation of  Radioiodinated MPR 46 
Immunoprecipitation of 125I-MPR 46 was performed essentially as previ- 
ously described (Nadimpalli et al., 1991). For competition experiments, 30 
#g of  affinity-purified  antibodies were preincubated with 300 #g of  decapep- 
tide in 100 #1 PBS containing 0.05 % Triton X-100 for 1 h at room tempera- 
ture. After adding 10 ug of 125I-MPR 46, the samples were incubated for 
30 rain at room temperature and overnight at 4"C. The immune complexes 
were adsorbed to Pansorbin (60 #1 of a  10%  suspension) (Calbiochem, 
Frankfurt a. M., Germany) for 1 h at 4"C, washed as described, solubilized, 
and subjected to SDS-PAGE under reducing conditions (Laemmli, 1970). 
After detection by fluorography, the bands corresponding to MPR 46 were 
cut from the gel to quantitate 1251-radioactivity by scintillation counting. 
Microinjection and Internalization of 
Endosomal Markers 
Cells were grown for 2 d on polylysine-coated coverslips. Microinjection 
was performed as previously described (Hille et al., 1992). After an incuba- 
tion for 0.5-3.0 h at 37°C, the cells were either fixed immediately for im- 
munofluorescence or loaded with endosomal markers. 
Internalization  of Antibodies  Against  MPR  46.  Cells  were prein- 
cubated for 2  x  30 rain at 37°C with bicarbonate-free MEM containing 10 
mM Hepes-NaOH, pH 7.4 (referred to as MEM-Hepes). The anti-MPR 46 
mAb 10C6 (A. Hille-Rehfeld, unpublished data) was offered at 0.2 mg/ml 
in MEM-Hepes for 10 min at 37°C. Cells were either washed immediately 
with ice-cold PBS and fixed for immunofluorescence, or washed twice with 
PBS (37°C), incubated for 20 rain at 37°C in MEM-Hepes, and then fixed. 
Where indicated, cycloheximide (final concentration 280 #M) was added 
to the culture medium 60 min before starting the microinjection, and all 
subsequent incubations were carried out in the presence of 280/zM cyclo- 
heximide. 
Internalization of Transferrin. Transferrin was saturated with iron as 
described (Klausner et al., 1983).  Cells were preincubated for 2  x  30 min 
in MEM-Hepes, and transferrin was offered to the cells at  1 mg/ml in 
MEM-Hepes for 30 min at 37°C. Internalization was stopped by rapid cool- 
ing on ice followed by two washes with ice-cold PBS and fixation for im- 
munofluorescence. 
Internalization Of  HRP. Cells were washed three times with PBS (37°C) 
and HRP (10 mg/ml in MEM-Hepes) (grade II; Boehriuger, Mannheim, 
Germany) was offered at 37°C. Internalization was stopped by rapid cooling 
on ice and three washes with ice-cold PBS. Cells were then incubated three 
times for 5 rain with ice-cold 5% FCS in PBS, followed by three washes 
with ice-cold PBS and fixation for immunofluorescence. 
Indirect Immunofluorescence 
Immunofluorescence was performed as described (Hille et al., 1992) using 
the following marker antibodies: MPR 46 was either labeled with the mouse 
mAb 10C6 or a polyclonal IgG raised in goat and purified using immobi- 
lized protein G (Wenk et al., 1991). MPR 300 was labeled with a polyclonal 
IgG raised in goat and likewise purified using immobilized protein G (Cau- 
sin et al., 1988).  The TGN was labeled with the mAb 100/3 directed against 
the .y-subunit of HA1 adaptors (Ahle et al., 1988).  Lysosomes were labeled 
with a polyclonal antiserum against cathepsin D raised in goat (Hasilik and 
Neufeld, 1980).  Early or late endosomes were labeled with afffinity-purified 
rabbit antibodies against rab5 or rab7, respectively (Chavrier et al., 1990). 
Internalized transferfin or HRP were detected with rabbit anti-human trans- 
ferrin (Janssen Biochemica, Beerse, Belgium) or goat anti-HRP antibodies 
(Sigma, Deisenhofen, Germany), respectively. Fluorochrome-labeled anti- 
bodies (Dianova,  Hamburg,  Germany) were preabsorbed against serum 
proteins from other species. Their specificity was confirmed, and cross- 
reactivity of primary or secondary antibodies was ruled out by control ex- 
periments with various combinations of antibodies. Injected Ig or Fab flag- 
ments were detected with donkey anti-rabbit Ig conjugated with AMCA; 
compartment-specific  marker  antibodies  were  detected  with  donkey 
anti-mouse Ig conjugated with Texas red or donkey anti-goat Ig conjugated 
with FITC. For simultaneous detection of injected Fab fragments from rab- 
bit and marker Ig raised in rabbit, we used goat anti-rabbit Ig conjugated 
with AMCA and goat anti-rabbit Fc conjugated with Texas red. 
Conventional ~ifluorescence was performed with an Axioplan micro- 
scope (Zeiss, Oberkochen, Germany) using the following filter combina- 
tions: G 365,  FT 395, BP 450-490 for detection of AMCA; BP 450-490, 
FT 510, LP 520 for detection of FI'IE; and BP 530-585,  FT 600, LP 615 
for detection of Texas red. For photographic documentation, confocal laser 
scanning microscopy (LSM; Zeiss) was performed as described (Hille et 
al.,  1992).  Stacks of confocal optical sections ("o0.8 #In thick) were used 
for serial overlay by digital image processing. 
Results 
Purification and Characterization of 
Peptide-specific Antibodies 
Polyclonal rabbit antibodies that recognize  15-mer peptides 
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Figure 1.  Antibodies against 
peptides within the cytoplas- 
mic domain of MPR 46.  (a) 
The synthetic 15-mer  peptides 
A and B were used to raise 
polyclonal  rabbit  antisera 
(Nadimpalli  et  al.,  1991); 
amino acid 1 corresponds to 
Arg-212, the first amino acid 
of  the  cytoplasmic  tail  of 
MPR  46;  (b)  immobilized 
peptides  used  for  affinity 
chromatography  of antibod- 
ies  against 15-mer peptides; 
(c)  overlapping decapeptides 
used  for affinity purification 
of antibodies against peptides 
38-42,  43-47, and 48-52. 
within the cytoplasmic tail of MPR 46,  corresponding to 
amino acids 7-21 or 38-52 (Fig. 1 a), were described earlier 
(Nadimpalli et al., 1991). These antibodies have been shown 
to be monospecific for MPR 46 by immunoprecipitation of 
the receptor from cell lysates. In addition, immunoprecipita- 
tion of radioiodinated MPR 46 was competed by the syn- 
thetic peptides used for immunization, but not by unrelated 
peptides.  For microinjection experiments, affinity-purified 
antibodies were prepared by affinity chromatography, using 
immobilized peptides 7-21  or 38-52  (Fig.  1 b). 
To obtain antibodies against smaller epitopes within pep- 
tide 38-52,  an antiserum against the  15-mer peptide was 
subfractionated by  sequential  affinity chromatography on 
three overlapping decapeptides (amino acids 33-42, 38-47, 
and 43-52)  that had been coupled to Affigel-10 with their 
NH2-terminal  amino  acid  (Fig.  1  c).  The  immobilized 
decapeptides had been designed in such a way that, starting 
from the  NH~-terminal end of peptide  38-52,  antibodies 
were consecutively  bound to the five amino acids that are ex- 
posed at the COOH terminus of each immobilized decapep- 
tide.  The five additional amino acids at the NH2-terminal 
side of the immobilized decapeptides served as a spacer arm, 
to minimize steric hindrance for binding of antibodies. The 
resulting  fractions  of antibodies  are  referred  to  as  anti- 
38-42,  anti-43--47  and anti-48-52,  according to the corre- 
sponding pentapeptide  epitopes.  The  two  latter  antibody 
fractions may recognize, in addition, epitopes that are con- 
stituted by the NH~-terminal boundaries of the pentapep- 
tides (amino acids 42/43 and 47/48). The affinity-purified  an- 
tibodies  were  shown  to  recognize  native  MPR  46  by 
immunoprecipitation of radioiodinated receptor (shown for 
immunoprecipitation with antibodies anti-43-47 in Fig. 2, 
third lane). The peptide specificity of the antibody fractions 
was proven by immunoprecipitation of radioiodinated MPR 
46 in the presence or absence of a  1,000-fold  molar excess 
of free decapeptides. As shown in Fig. 2 for antibodies anti- 
43-47,  the decapeptide  38-47,  which had been  used  for 
affinity purification, efficiently competed immunoprecipita- 
tion  (fourth  lane).  Competition  was  also  observed  with 
decapeptide 43-52  (fifth lane), which overlaps the peptide 
used for affinity purifcation, exposing the peptide 43-47 at 
its  NH2-terminal  end.  Decapeptides  that  correspond  to 
amino acids adjoining the NH2- or COOH-terminal end of 
peptide 43-47  did not compete (sixth and seventh lanes). 
Similar results were obtained for the antibodies anti-38--42 
and anti-48-52 (not shown). These results demonstrate the 
peptide-specificity of the antibody fractions which were ob- 
tained by affinity chromatography. 
Redistribution of  MPR 46 by Microinjection of 
Peptide-specific Antibodies Against Amino Acids 
38-52 of  Its Cytoplasmic Tail 
Fab fragments that recognize the  15-mer peptides 7-21  or 
38-52 were injected into human skin fibroblasts, and cells 
were incubated for up to 3 h at 37°C to allow binding of the 
injected antibodies to the cytoplasmic domain of MPR 46. 
The cells were then fixed, permeabilized, and processed for 
immunofluorescence  to compare the steady state distribution 
of MPR 46 in control cells and injected cells. Injected cells 
were identified by coinjected FITC-BSA (Fig. 3, c and d). 
To  visualize the  distribution of MPR 46,  a  mouse mAb 
(10C6),  which recognizes the lumenal domain of MPR 46 
and does not interfere with binding of the injected antibod- 
ies,  was  used in combination with Texas  red-conjugated 
anti-mouse Ig as a second antibody (Fig. 3, a and b). In non- 
injected cells (cells on the left in Fig. 3, a and b), the highest 
Figure 2. Peptide-specific  im- 
munoprecipitation  of  MPR 
46.  Immunoprecipitation  of 
radioiodinated MPR 46  was 
performed  with  affinity-pu- 
rified Ig against whole MPR 
46 (¢tMPR  46), preimmune Ig 
(PI),  or  affinity-purified Ig 
against  peptide  43--47 
(~43-47), which corresponds 
to  part  of  the  cytoplasmic 
domain of MPR 46 (compare 
Fig. 1). Where indicated, anti- 
bodies  were  preincubated 
with  an  excess of synthetic 
peptide.  Immunoprecipitates 
were analyzed by SDS-PAGE, 
and MPR 46 was detected by 
fluorography. M, monomeric 
MPR  46;  D,  SDS-resistant 
dimer of MPR 46. 
Schulze-Garg  et  al.  Antibody-induced Redistribution of MPR 46  543 Figure 3. Redistribution of MPR 46 by microinjected F~, fragments against peptide 38-52. Human fibroblasts were microinjected with 
F~ fragments (9 mg/ml) against peptide 7-21 (left panels) or against peptide 38-52 (right panels).  30 min (a-d) or 120 rain (e and f) 
after injection, cells were fixed  and processed for immunofluorescence detection of MPR 46 (a, b, e, and f). Coinjected FITC-BSA (0.5 
mg/ml) is shown in c and d. a and b show the same sector as c and d, respectively. Asterisks in e and f  indicate injected cells that had 
been identified by immunofluorescence staining of injected antibodies. Bars, 20/zm. 
labeling for MPR 46 was found in perinuclear, tubular struc- 
tures which colocalized with HA-1 adaptors as a marker for 
the TGN (see below, Fig. 5, a and b). In addition, MPR 46 
was found in vesicular structures in the periphery of non- 
injected cells, which partially colocaiized with endocytosed 
transferrin  (not  shown).  Microinjection  of Fa~  fragments 
against peptide 38-52 caused redistribution of  MPR 46 from 
the TGN to vesicular structures that were scattered through- 
out the cytoplasm (cell on the right in Fig. 3 b). Already 30 
rain after injection, the TGN was almost devoid of MPR 46 
(Fig. 3 b) and the effect was stable for at least 3 h  (shown 
for 2  h,  Fig.  3 f).  After microinjection of Fe fragments 
against  peptide  %21,  the  immunofluorescence pattern  of 
MPR 46 was not changed, neither 30 min after microinjec- 
tion  (Fig.  3  a)  nor at  later time points  (up to  3  h  after 
microinjection, Fig. 3 e). For both peptides, injection of Ig 
provided results that were indistinguishable from those de- 
scribed above for injection of F.b fragments (compare Fig. 
4 a  for injection of anti 38-52 Ig). Injection of preimmune 
rabbit IgG or injection of  buffer alone did not change the ira- 
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redistribution of MPR 46. Human fibroblasts were microinjected 
with antibodies against peptide 38-52 (1 mg/ml) together with pep- 
tide 7--21 (a) or peptide 38-52 (b) (10 mg/ml each). 90 rain after 
injection, cells were fixed and processed for immunofluorescence 
detection of MPR 46. Only injected cells are shown, which were 
identified by immunofluorescence detection of injected Ig. Bar, 
20 #m. 
munofluorescence pattern of MPR 46, except for a slight and 
fully  reversible  distortion  of the  TGN  at  ~5  min  after 
microinjection (not shown). 
The  fact  that  antibodies  against  peptide  7-21  did  not 
change  the  distribution  of MPR  46  raised  the  question 
whether the epitope 7-21 is accessible in situ for binding of 
injected antibodies to the cytoplasmic domain of MPR 46. 
We therefore investigated whether injected antibodies were 
bound to membranes containing MPR 46.  In human fibro- 
blasts, which express relatively low amounts of endogenous 
MPR 46, it was difficult to detect membrane-bound injected 
antibodies because the cytosol was filled with excess un- 
bound antibodies.  In transfected Ltk-cells, which overex- 
press human MPR 46, Ig against peptides 7-21  and 38-52 
were both bound to membranes which contain MPR 46 but, 
as in fibroblasts, redistribution was observed only with Ig 
against peptide 38-52  (not shown). 
Redistribution of MPR 46 by Ig against peptide 38-52 was 
completely abolished by coinjected peptide 38-52 at about 
1,300-fold molar excess (Fig. 4 b), but not by the same con- 
centration of the irrelevant peptide 7-21 (Fig. 4 a). This re- 
sult confirms that antibody-induced redistribution of MPR 
46 was a result of specific binding of antibodies to the epi- 
tope 38-52 within the cytoplasmic domain of MPR 46. 
We next sought to find out which part ofpeptide 38-52 was 
responsible for antibody-induced redistribution of MPR 46. 
F, fragments against the three peptides 38-42,  43-47,  or 
48-52  were microinjected, and redistribution of MPR 46 
was monitored by comparing the immunofluorescence pat- 
tern of  MPR 46 (Fig. 5, upper  panel) with that of HA-1 adap- 
tors (Fig. 5, lower  panel) as a marker for the TGN (Ahle et 
al.,  1988;  Geuze et al.,  1991). F, fragments against the 
peptide 38-42 did not change the immunofluorescence pat- 
tern of MPR 46. As in non-injected control cells, MPR 46 
was found in perinuclear tubular structures, which were also 
labeled for HA1 adaptors, and in peripheral endosomal vesi- 
cles (Fig. 5, a-d). Fib fragments against the central peptide 
43-47 efficiently caused redistribution of MPR 46 from the 
TGN into vesicular structures which were scattered through- 
out the cytoplasm (Fig. 5, e and  f), and which were indistin- 
guishable from those obtained upon microinjection of anti- 
bodies against the 15-mer peptide 38-52. Microinjection of 
F,  fragments against the  COOH-terminal peptide 48-52 
also caused the disappearance of  MPR 46 from the TGN, but 
the vesicular staining for MPR 46 was less pronounced com- 
pared with cells that had been microinjected with F, frag- 
ments against peptide 43--47 (Fig. 5, g and h). For all three 
peptides, similar results were obtained with injected Ig (not 
shown).  We therefore can exclude that the failure of F, 
fragments against peptide 38-42 to induce redistribution of 
MPR 46 resulted from proteolytic cleavage of  the Ig. The im- 
munofluorescence pattern of HA1  adaptors (Fig.  5,  lower 
panel) and galactosyltransferase (not shown) was not altered 
by any of the microinjected antibodies, suggesting that the 
structure of the TGN had not been disturbed. 
Recent reports  that the tyrosine residue within peptide 
43-47 is relevant for endocytosis of bovine MPR 46 which 
was overexpressed in mouse L-cells (Johnson et al.,  1990) 
raised the question whether redistribution of MPR 46 by an- 
tibodies against peptide 43-47  may result in arrest of the 
Figure 5.  Redistribution of MPR 46 by microinjection of F~b fragments against peptides 43-47  and 48-52.  Human fibroblasts were 
microinjected with antibodies against peptides 38-42 (7.6 mg/ml), 43-47  (9 mg/ml), or 48-52 (9 mg/ml). 90 min after injection, cells 
were fixed  and processed for simultaneous immunofluorescence  detection of  MPR 46 (upper  panels) and 7-adaptin (Iowerpanels). Injected 
cells were identified by detection of injected Fab fragments. Pairs of vertically aligned panels show double staining of one cell. Bar, 
20 #m. 
Schuize-Garg et al. Antibody-induced Redistribution of MPR 46  545 Figure 6. Injected Fe fragments do not cause missorting of MPR 
46 to lysosomes. Human fibroblasts were microinjected with anti- 
bodies against peptide 43--47 (4.5 mg/ml). 90 min after injection, 
ceils were fixed and processed for simultaneous immunofluores- 
cence detection of MPR 46 (a, c, e, and g) and cathepsin D (b, d, 
f, and h). Injected cells were identified  by detection of injected F,b 
fragments. Cells shown  in c, d, g, and h were treated with leupeptin 
and pepstatin (final concentration 100/~M each) starting from 17 
h before microinjection and throughout  until cells were fixed. Pairs 
of  vertically aligned cells (a/b, c/d, elf, and g/h) show  double stain- 
ing of one cell. Bar, 20 #m. 
receptor at the plasma membrane. We therefore investigated 
the cell surface pattern of MPR 46 after microinjection of 
Fab fragments against peptide 43-47 by immunolabeling of 
cells which had not been permeabilized. The cell surface 
staining of nonpermeabilized cells showed a  faint, diffuse 
immunolabeling, which was similar in injected and control 
cells (not shown). The dots containing redistributed MPR 46 
were accessible to immtmolabeling by the monoclonal anti- 
body against the luminal domain only after permeabilization 
of cells. These data suggest that the bulk of redistributed 
MPR 46 is contained in an intracellular compartment. 
The observed redistribution of MPR 46 may reflect ar- 
rested trafficking of MPR 46, resulting in accumulation of 
the receptor within a compartment that is part of its normal 
recycling pathway. Alternatively, it may reflect missorting of 
the receptor to lysosomes due to tagging of the cytoplasmic 
domain with Fe fragments. To investigate this  issue,  the 
immunofluorescence pattern of MPR 46 was compared with 
that of the lysosomal enzyme cathepsin D. In non-injected 
cells (Fig. 6, a and b) there was essentially no overlap in the 
distribution of MPR 46 (a) and cathepsin D (b), as was ex- 
pected  according  to  the  recycling  pathway  of  MPR  46 
(reviewed by Kornfeld and Mellman, 1989).  Occasionally, 
few vesicular structures were found to be labeled for both 
MPR 46 and cathepsin D, which may be explained by the fact 
that newly synthesized cathepsin D, like any lysosomal anti- 
gen, must pass through the endosomai compartment on its 
way  to  lysosomes.  In  cells  injected  with  F.b  fragments 
against peptides 43-47 or 48-52, there was no evidence for 
increased colocalization of MPR 46 and cathepsin D (shown 
for injection of anti-peptide 43-47 in Fig. 6, e and  f). To ex- 
clude a missorting of  redistributed MPR 46 to lysosomes and 
rapid degradation therein, cells were treated with the pro- 
tease inhibitors leupeptin and pepstatin, which have been 
shown earlier to prevent degradation of a mutant form of 
MPR 46  which is  missorted to lysosomes (Peters  et al., 
1990).  Also in cells that had been injected in the presence 
of protease irdaibitors,  there was no substantial colocaliza- 
tion of redistributed MPR 46 (Fig. 6 g) with cathepsin D 
(Fig. 6 h), suggesting that redistributed MPR 46 is neither 
missorted to nor degraded within lysosomes. 
Redistributed MPR 46 Accumulates in an 
Endosomal Subcompartment 
To investigate whether redistributed MPR 46 resides in an 
endosomai compartment, cells were loaded with the mAb 
10C6 against the extracellular or ecto-domain of MPR 46, 
which is specifically imported by MPR 46 that recycles be- 
tween cell surface and endosomes (see Stein et al.,  1987). 
These studies were carried out with BHK-cells overexpress- 
ing human MPR 46 (BI-IK-MPR 46 cells), because cell sur- 
face expression of MPR 46 in human fibroblasts was too low 
to detect import of anti-MPR 46 antibodies. Injection of F,b 
fragments against peptide 43-47  into BHK-MPR 46 ceils 
resulted in redistribution of MPR 46 from the perinuclear re- 
gion (Fig.  7  a)  to small vesicles scattered throughout the 
cytoplasm, indicating that also in these cells the microin- 
jected  antibodies  block  transport  of  MPR  46  to  the 
perinuclear region (shown in Fig. 7 c for a cell that had been 
fixed and processed for immunofluorescence 70 min after 
microinjection). 
In non-injected BHK-MPR 46 cells, ectodomain antibod- 
ies that had been internalized continously for 10 rain at 37°C 
(Fig. 7 b) colocaiized with MPR 46 (Fig. 7 a) in peripheral 
endosomal vesicles, but not with MPR 46 in perinuclear, 
Golgi-like structures. In contrast, redistributed MPR 46 in 
injected cells (Fig. 7 c) did not colocalize with ectodomain 
antibodies that had been internalized for 10 min (Fig. 7 d). 
Only  after  30  rain  of continuous  internalization,  partial 
colocalization of internalized ectodomain antibodies  and 
redistributed MPR 46 was observed (not shown). When ec- 
todomain antibodies were offered to the cells for 10 min fol- 
lowed by a chase of 20 min, the great majority of the struc- 
tures  containing  redistributed  MPR  46  (Fig.  7  g)  were 
labeled with endocytosed ectodomain antibodies (Fig. 7 h). 
To investigate whether loading of  endosomes with endocy- 
tosed anti-MPR 46 antibodies in injected cells indicates re- 
cycling of redistributed MPR 46  between the endosomal 
compartment and the plasma membrane, or whether inter- 
nalization depended on newly synthesized MPR 46, protein 
synthesis was blocked by incubation with cycloheximide. 
Treatment  of cells  with  280  /~M  cycloheximide reduced 
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distributed  MPR  46  is  accessible  to 
endocytosed  antibodies.  BHK  ceils 
overexpressing  human  MPR  46  were 
microinjected  with  F,b  fragments 
against peptide 43-47 (4.5 mg/ml).  60 
min after injection, cells were incubated 
for 10 min with a mouse mAb against 
the extracellular domain of MPR 46 and 
fixed either immediately  (a-d) or after 
a chase of 20 rain (e-h). Cells were then 
permeabilized  for  simultaneous  im- 
munofluorescence staining of total cel- 
lular MPR 46 with goat antibody (a, c, 
e, and g) and internalized  mouse anti- 
MPR 46 antibody  (b, d, f, and h).  In- 
jected cells were identified by detection 
of injected rabbit F,b fragment.  Pairs of 
vertically  aligned panels  (a/b,  c/d,  e/f, 
and  g/h)  show double  staining  of one 
cell. Arrows point to some of the struc- 
tures that show labeling for both endoey- 
tosed  anti-MPR  46  and  total  cellular 
MPR 46.  Bars,  10 #m. 
[35S]methionine  incorporation into  newly synthesized pro- 
teins to ~10%  of the control value within 30 min, and to 
"~5 % within 60 min (not shown).  To make sure that MPR 
46 which had been synthesized before addition of cyclohexi- 
mide  had  left the  biosynthetic  pathway  (see  Hille  et  al., 
1990), cells were incubated with 280 #M cycloheximide for 
a total of 2 h before anti-MPR 46 antibodies were offered for 
endocytosis.  Also after treatment with cycloheximide, en- 
docytosed  anti-MPR  46  antibodies  colocalized  with  total 
cellular MPR 46 both in non-injected and injected cells (not 
shown). This indicates that redistributed MPR 46 is not im- 
mobilized but can recycle to the plasma membrane. 
Colocalization  of  endocytosed  ectodomain  antibodies 
with redistributed MPR 46 was also observed at 20°C, i.e., 
under conditions of arrested transport from early to late en- 
dosomes (Marsh et al.,  1983).  After 10 rain of internaliza- 
tion at 20°C, a 50-min chase was necessary to obtain a simi- 
lar degree of colocalization as after a 20 min chase at 37°C 
(not shown). Since incubation at reduced temperature results 
in transient arrest rather than irreversible blockade of trans- 
port, it was important to control the efficiency of the arrest 
under the conditions used. When receptor-mediated endocy- 
tosis of arylsulfatase A was followed at 20°C in BHK-celIs, 
transport to dense lysosomes did not occur for at least 75 min 
during a continous incubation with arylsulfatase A-contain- 
ing medium,  whereas at 37°C  about 45 %  of endocytosed 
arylsulfatase A  was found in the dense lysosomal fraction 
(R. Bresciani and K. von Figura, unpublished observations). 
These data suggest efficient arrest within the endocytic path- 
way at 20°C. Therefore, colocalization of redistributed MPR 
46 with ectodomain antibodies internalized at 20°C suggests 
that the pathway of MPR 46 from the cell surface to the corn- 
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dosomal markers rab5, rab7, or HRP. Human fibroblasts were 
microinjected  with  Fab  fragments against peptide  43--47  (9 
mg/ml). 90 min after injection, cells were either fixed immediately 
or loaded for 30 min with HRP and then fixed. Cells were then 
processed for simultaneous immunofluoreseence  detection of MPR 
46 (a, c, e, g, i, and l), and either rab5 (b and h), rab7 (d and k), 
or HRP (fand m). Injected cells were identified by detection of in- 
jected F,b fragments. Pairs of vertically aligned panels (a/b, c/d, 
e/f g/h, i/k, and l/m) show double staining of one cell. Note that 
e, f, l, and m are shown with higher magnification  then the upper 
panels a-d and g-k. Bars, 20 #m 
partment of redistributed MPR 46 does not pass beyond the 
site of the 20°C block. 
To further characterize the compartment of redistributed 
MPR  46,  double  immunofluorescence staining  was  per- 
formed with various endosomal markers. Rab5 (Fig. 8, b and 
h) and rab7 (Fig. 8, d and k), which bind to the cytoplasmic 
face of early and late endosomes, respectively (Chavrier et 
ai.,  1990),  showed a vesicular pattern which is typical for 
endosomes. In non-injected control cells, rab5 (Fig. 8 b) oc- 
casionally co!ocalized with MPR 46 (Fig. 8 a) in peripheral 
vesicular structures as shown by overlay of confocal images 
(not visible in Fig. 8), whereas rab7 (Fig. 8 d) was not detect- 
able in vesicular structures containing MPR 46 (Fig. 8 c). 
Conversely, MPR 300 partially colocalized with rab7, but es- 
sentially not with rab5  (not shown).  When the immuno- 
fluorescence pattern of redistributed MPR 46 in microin- 
jected cells (Fig. 8, g and i) was compared with that of rab5 
(Fig. 8 h) or rab7 (Fig. 8 k), colocalization was found rarely. 
Endoeytosed transferrin,  another marker  for early endo- 
somes (Schmid et al.,  1988 and references cited therein), 
also  showed partial colocalization with MPR 46  in non- 
injected cells, but very little if any with redistributed MPR 
46 in injected cells (not shown). MPR 300 (Fig. 9 b) showed 
a high degree of colocalization with MPR 46 in non-injected 
ceils or cells injected with control antibodies (Fig.  9  a), 
which was especially evident in the perinuclear region. After 
microinjection of F,b fragments against peptides 43-47  or 
48-52, the immunofluorescence pattern of MPR 300 (Fig. 
9, d and  f) was not changed and, in contrast to control cells, 
did not overlap with that of redistributed MPR 46 (Fig. 9, 
c and e). Endocytosed HRP as a marker for fluid-phase up- 
take has been shown to label the endocytic route all along 
the way to lysosomes (for review see Helenius et al., 1983). 
When microinjected cells were loaded for 15, 30, or 60 rain 
with HRP (shown for the 30-min time point in Fig. 8, fand 
m), there was little colocalization with MPR 46 both in con- 
trol and injected cells (Fig. 8, e and l, respectively). 
Taken together,  these  results  suggest that redistributed 
MPR 46 accumulates in an as yet unidentified endosomal 
subcompartment which is accessible to endocytosed anti- 
bodies  but  is  separate  from the  general  endoeytic route 
which leads to the lysosome. 
Discussion 
Antibody-induced Redistribution of  MPR 46 to an 
Endosomal Subcompartment 
MPR 46 recycles between TGN and endosomes for sorting 
of newly synthesized lysosomal enzymes. In addition, MPR 
46  recycles  between  endosomes  and  plasma  membrane 
(Duncan  and  Kornfeld,  1988;  Stein  et  al.,  1987).  Im- 
munofluorescence staining showed that in human fibroblasts 
the major portion of MPR 46 is localized in the TGN, sug- 
gesting that exit from the TGN where newly synthesized 
lysosomai enzymes are bound is the rate limiting step in 
transport of MPR 46,  whereas return from endosomes oc- 
curs rapidly in these cells. 
Microinjection  of  Fa~  fragments  against  the  peptide 
43-47 resulted in rapid and efficient redistribution of MPR 
46 from the TGN to vesicular structures that were scattered 
throughout the cytoplasm. The use of monovaient F~, frag- 
ments precluded possible artifacts due to antibody-induced 
cross-linking.  Moreover,  redistributed  receptor  did  not 
colocaiize with cathepsin D, indicating that tagging with the 
Fab  fragments  did  not  induce  missorting  to  lysosomes. 
Redistributed MPR 46 mediated import of antibodies against 
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bution is specific for MPR 46. Hu- 
man fibroblasts were microinjected 
with F~, fragments against peptides 
38-42 (a and b), 43-47 (c and d) or 
48-52 (e and f). For concentrations 
of injected F.b see Fig. 5. 90 rain af- 
ter injection,  cells  were  fixed and 
processed  for simultaneous  immu- 
nofluorescence detection of MPR 46 
(upper  panels) and MPR 300 (lower 
panels).  Injected  cells  were 
identified  by  detection  of injected 
F~  fragments.  Pairs  of  vertically 
aligned panels show double staining 
of one cell. Bar, 20 #m. 
its  extracytoplasmic domain  under  conditions  of blocked 
protein synthesis. This result suggests that MPR 46 was not 
immobilized by the bound antibodies, and recycling between 
endosomes and the plasma membrane was not blocked. 
Antibody-induced redistribution was selectively observed 
for MPR 46, the immunofluorescence pattern of markers for 
TGN, endosomes or lysosomes being unchanged.  Remark- 
ably,  the  intracellular  distribution  of  MPR  300,  which 
contains a sequence motif similar to peptide 43-47 (Tyr-X- 
X-Val, see Oshima et al., 1988), was not changed in microin- 
jected cells,  suggesting that the peptide-specific antibodies 
did not cross react with epitopes that are relevant for trans- 
port of MPR 300. 
The compartment of  redistributed MPR 46 did not contain 
HA-1  adaptors  or galactosyltransferase as  markers  of the 
TGN or Golgi cisternae (Geuze et al.,  1991; Nilsson et al., 
1993),  whereas  essentially  all  the  structures  containing 
redistributed MPR 46 were accessible to endocytosed ec- 
todomain antibodies. These results suggest that redistributed 
MPR 46 resides in a compartment which is connected to the 
endosomal pathway.  Lack of colocalization of redistributed 
MPR 46 with a  fluid-phase marker and with markers for 
early or late endosomes suggests that the compartment of 
redistributed MPR 46 is separate from the main route of en- 
docytic traffic which leads to lysosomes. In this context, it 
is interesting that recent results obtained by immunoelectron 
microscopy have shown the presence of MPR 46 in tubular 
extensions of both early and late endosomes, which do not 
contain  asialoglycoprotein receptor,  and  which  are  only 
rarely stained by fluid-phase markers (Klumperman et al., 
1993). These data suggest that within endosomes, MPR 46 
is segregated into membranes which exclude material des- 
tined for return to the plasma membrane (asialoglycoprotein 
receptor) or for transport to lysosomes (fluid-phase marker) 
and which may be involved in segregation of MPR 46 for re- 
turn to the TGN.  The data presented here are compatible 
with the view that the compartment of redistributed MPR 46 
is related to or derived from the above mentioned tubular ex- 
tensions of endosomes seen in immunoelectron microscopy. 
The compartment of redistributed receptor may therefore 
constitute an intermediate compartment which is involved in 
segregation of MPR 46 from the general endoeytic route, 
which  leads  to  lysosomes.  This  compartment  is  located 
proximal to the 20°C block within endosomes and must be 
passed by MPR 46 before it returns to the TGN. To charac- 
terize the ultrastrncture of the compartment of redistributed 
MPR 46 by immunoelectron microscopy, and to investigate 
its molecular composition as well as its function is the aim 
of our future studies. The elucidation of its putative function 
in sorting and vesicular transport of MPR 46 will depend on 
the production of antibodies that  specifically bind to this 
compartment. 
Sorting Events Involved in Recycling of  MPR 46  from 
Endosomal Membranes 
Antibody-induced  redistribution  of MPR  46  can  be  ex- 
plained by blockade of a single transport step. Blockade of 
transport either from endosomal membranes to the TGN, or 
within the endosomal compartment are both  sufficient to 
shift the main localization of MPR 46 from the TGN to en- 
dosomal  membranes.  Since  microinjected  F~  fragments 
anti-43--47 inhibit return of MPR 46 to the TGN, binding of 
F,b fragments to peptide 43--47 in the cytoplasmic domain 
of MPR 46 most likely masks information contained within 
this epitope, which is required for return of MPR 46 to the 
TGN. The sorting step which is affected by F~ fragments 
anti-43--47 may reside either directly at the exit site from en- 
dosomal membranes or at an earlier transport step between 
different membranes of the endosomal pathway.  From our 
data, there is no evidence that recycling to the plasma mem- 
brane is affected by binding of F,b fragments anti-43--47. 
The effect of blocking antibodies can be explained either 
by competition with binding of cytosolic transport factors to 
the cytoplasmic domain of MPR 46, or by interference with 
changes in the conformation or quaternary structure of MPR 
46 that may be essential for its recycling to the TGN. If the 
epitope of  the blocking antibodies is part of a signal for bind- 
ing of  cytosolic transport factors, then the peptide may be ex- 
pected to interact with cytosolic transport factors and com- 
pete with their binding to the cytoplasmic domain of MPR 
46, and therefore cause a similar redistribution of MPR 46 
as was observed after injection of peptide-specific antibod- 
ies. In our hands, peptide 38-52, when injected into fibro- 
blasts at a concentration of 10 mg/ml did not cause redistri- 
bution of MPR 46 (not shown), whereas antibody-induced 
redistribution of MPR 46 was prevented by coinjecting the 
peptide at the same concentration. There are two feasible ex- 
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by injection of the peptide alone. First, the affinity  of  the syn- 
thetic peptide to cytosolic transport factors may be too low 
to compete with receptors in situ, if the conformation of the 
15-met peptide in solution differs from that of the corre- 
sponding peptide within the cytoplasmic domain of MPR 46. 
Alternatively, the peptide may be rapidly degraded by cyto- 
solic proteases when injected alone without being complexed 
by coinjected Ig. It will be interesting to investigate whether 
peptides containing the epitope 43-47 are capable of  binding 
cytosolic proteins, or proteins associated with the cytoplas- 
mic face of endosomal membranes or transport vesicles, 
using an in vitro assay. 
Is T)~osine 44 Part of a Multifunctional Signal 
Involved in Sorting at the Plasma Membrane and 
IntraceUular  TraJHic? 
Recent results obtained by in vitro mutagenesis of aromatic 
amino acids in the cytoplasmic domain of  MPR 46 suggested 
that amino acid residue Tyr-44 is part of a signal for efficient 
endocytosis of MPR 46 (Johnson et al.,  1990).  Moreover, 
the peptide 43-47 (Ala-Tyr-Arg-Gly-Val) displays some ho- 
mology to peptide sequences that were shown to bind plasma 
membrane coated vesicle adaptors (reviewed by Pearse and 
Robinson,  1990).  Binding  of antibodies  against  peptide 
43-47 to the cytoplasmic domain of MPR 46 may therefore 
be expected to interfere with binding of plasma membrane 
adaptors and with clathrin-mediated endocytosis of MPR 46. 
It was, therefore, surprising that antibodies against peptide 
43-47 interfered with an intracellular sorting step. These ap- 
parently conflicting results may be explained by the assump- 
tion that the epitope surrounding Tyr-44 is part of a mul- 
tifunctional signal, which binds several different transport 
factors involved in endocytosis or in intracellular sorting. 
Such a multifunctional signal can be compared to a master 
key which opens different locks. The binding of cytosolic 
transport factors to their specifc target membranes must 
then be determined either by a third component that is pres- 
ent in or associated with the target membrane, or by confor- 
mational changes in the cytoplasmic domain of the receptor. 
The latter may modulate the signal depending on the mem- 
brane in which the receptor resides. The assumption that one 
signal may be involved in several sorting events is supported 
by recent reports that the tyrosine-containing signal for en- 
docytosis is also involved in polar sorting of several recep- 
tors and lysosomal acid phosphatase from the TGN to the 
basolateral plasma membrane in epithelial cells (Brewer and 
Roth,  1991; Casanova et al.,  1991; Hunziker et al.,  1991; 
Prill et al.,  1993).  If "l~yr-44 of MPR 46 is part of a mul- 
tifunctional sorting signal involved both in endocytosis and 
intracellular sorting, one should observe antibody-induced 
accumulation of MPR 46  both  in  endosomes and at the 
plasma membrane. Since binding of antibodies to the puta- 
tive internalization signal may cause a reduction in the rate 
of internalization rather than a blockade, as was the case af- 
ter mutagenesis of the signal (Johnson et al.,  1990),  the 
resulting increase of the steady state concentration of MPR 
46 at the plasma membrane might be too low to be detected 
by immunofluorescence. Similarly, if tagging of MPR 46 by 
microinjected  F~  fragments  induces  internalization,  the 
steady state concentration of MPR 46 at the plasma mem- 
brane may increase little, if at all. Alternatively, the failure 
to detect antibody-induced accumulation of MPR 46 at the 
plasma membrane may be explained by the assumption that 
plasma membrane adaptors have a  higher affinity for the 
multi  functional signal than putative transport, factors binding 
to the signal at the endosome. Sorting at the endosome thus 
would be more sensitive for interference by microinjected 
antibodies. 
Conclusion 
Our results show that microinjection of  peptide-specific anti- 
bodies and immunocytochemistry can be used to identify 
epitopes within the cytoplasmic domain of MPR 46 which 
are relevant for its intracellular transport. To further charac- 
terize the signals and putative cytosolic transport factors in- 
volved in exit of MPR 46 from the endosomal pathway, com- 
plementary biochemical and cell biological studies need to 
be done. So far, our data suggest that return from endosomes 
to the TGN is not a bulk flow process, but requires specific 
sorting signals. 
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